Leica Biosystems Acquires Cell IDx
Leica Biosystems acquired San Diego-based Cell IDx, Inc. Terms of the deal were not disclosed. Founded in 2012, Cell IDx provides multiplex staining panels, tissue staining and imaging and analysis services. Buffalo Grove, Illinois-based Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions. In 2021, Leica Biosystems and Cell IDx announced a partnership to combine the benefits of UltraPlex and BOND RX. According to the LevinPro HC database, this was the 123rd Biotechnology transaction of 2022. This compares with 103 Biotechnology deals recorded between January 1, 2021, and November 10, 2021. Read More »
Avista Capital Partners Acquires Taconic Biosciences
Avista Capital Partners has acquired Taconic Biosciences from H.I.G. Capital. Transaction terms were not disclosed. Founded in 1952 and headquartered in Rensselaer, New York, Taconic Biosciences specializes in genetically engineered research models and services, specifically murine models for use in drug discovery research and non-clinical safety testing. Founded in 2005, Avista Capital is a New York-based private equity firm with more than $8 billion invested in more than 40 growth-oriented healthcare businesses globally. According to the LevinPro HC database, this was the 122nd Biotechnology transaction of 2022. This compares with 103 Biotechnology deals recorded between January 1, 2021,... Read More »
Syncona Limited Acquires Applied Genetic Technologies Corporation for $23.5 Million
Syncona Limited has acquired Applied Genetic Technologies Corporation. The tender offer is for approximately $23.5 million in cash plus potential future aggregate cash payments of up to $50 million pursuant to contingent value rights. London-based Syncona focuses on founding, building and funding global leaders in life science. Applied Genetic Technologies Corporation is a clinical-stage biotechnology company focused on the development and commercialization of adeno-associated, virus-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases. According to the LevinPro HC database, this is the 116th Biotechnology deal of... Read More »
Beckley Psytech Limited Acquires Eleusis Therapeutics Limited
Beckley Psytech Limited acquired Eleusis Therapeutics Limited. The companies are located in the UK. Terms of the deal were not disclosed. Beckley Psytech is a clinical-stage privately held company helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds. Founded in 2013, Eleusis is a clinical-stage life science company that aims to unlock the potential of psychedelics, guided by science and enabled by drug discovery, clinical development and care delivery design. According to the LevinPro HC database, this was the 116th Biotechnology deal of 2022. That compares with 100 Biotechnology transactions recorded between January 1,... Read More »
Eli Lilly Acquires Akouos
Eli Lilly and Company has acquired Boston-based Akouos, Inc. The transaction is valued at approximately $487 million plus a contingent value right for an aggregate amount up to approximately $610 million. Akouos, Inc. is a precision genetic medicine company that is developing a portfolio of adeno-associated viral gene therapies for the treatment of inner ear conditions, including sensorineural hearing loss. Eli Lilly discovers, develops, manufactures and sells pharmaceutical products. Its products are sold in 125 countries. According to the LevinPro HC database, this acquisition is the 113th Biotechnology deal of the year. This compares with 100 Biotechnology transactions from January 1,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
